4//SEC Filing
Revance Therapeutics, Inc. 4
Accession 0001209191-14-058905
CIK 0001479290operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:26 PM ET
Size
10.5 KB
Accession
0001209191-14-058905
Insider Transaction Report
Form 4
BYRNES ROBERT F
Director
Transactions
- Exercise/Conversion
Common Stock
2014-09-17$3.60/sh+2,666$9,598→ 2,666 total - Gift
Common Stock
2014-09-17+2,666→ 2,666 total(indirect: By Trust) - Exercise/Conversion
Stock Option (Right to Buy)
2014-09-17−2,666→ 0 totalExercise: $3.60Exp: 2014-10-25→ Common Stock (2,666 underlying) - Gift
Common Stock
2014-09-17−2,666→ 0 total
Footnotes (3)
- [F1]This transaction reflects an option exercise by the Reporting Person directly to The Byrnes Family Trust, of which the Reporting Person is the trustee.
- [F2]Represents transfer of shares to the Reporting Person's Family Trust. The Reporting Person continues to beneficially own such shares through indirect ownership through The Byrnes Family Trust as reported in Table I.
- [F3]The Option is fully vested as of October 26, 2008.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:26 PM ET
- Size
- 10.5 KB